Tag Archives: BPMUF

Top 10 Medical Stocks To Own Right Now

Primo Water (NASDAQ:PRMW) had its price objective hoisted by analysts at BMO Capital Markets from $15.00 to $16.00 in a research note issued on Thursday. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 0.88% from the company’s current price.

PRMW has been the subject of a number of other research reports. ValuEngine upgraded shares of Primo Water from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. BidaskClub lowered shares of Primo Water from a “hold” rating to a “sell” rating in a research note on Tuesday, March 13th. Barrington Research restated a “buy” rating and set a $20.00 price target on shares of Primo Water in a research note on Friday, April 6th. B. Riley set a $18.00 price target on shares of Primo Water and gave the company a “buy” rating in a research note on Monday, March 5th. Finally, William Blair began coverage on shares of Primo Water in a research note on Thursday. They set an “outperform” rating for the company. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $17.50.

Top 10 Medical Stocks To Own Right Now: THL Credit Senior Loan Fund(TSLF)

THL Credit Senior Loan Fund is a non-diversified, closed-end management investment company (Fund). The Fund’s investment objective is to provide current income and preservation of capital primarily through investments in United States dollar-denominated senior secured corporate loans and notes. Under normal market conditions, the Fund will invest 100% of its Managed Assets in the securities of issuers located in North America and does not currently intend to invest a material amount of its Managed Assets outside the United States. It invests in sectors, such as Business, Services, Healthcare and Pharmaceuticals, Retail, Software, Advertising, Printing and Publishing, and Diversified and Services, among others. Four Wood Capital Advisors LLC serves as the Fund’s investment adviser. Advisors’ Opinion:

Top 10 Medical Stocks To Own Right Now: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The company’s preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

  • [By Cory Renauer]

    If you’re looking for biotech stock bargains, the scrap heap isn’t a bad place to start. Hardly a day goes by without a biotech meltdown somewhere, and clinical trial mishaps led to market clubbings for Anika Therapeutics (NASDAQ:ANIK) and Catalyst Biosciences (NASDAQ:CBIO) earlier this week.

Top 10 Medical Stocks To Own Right Now: RELX PLC(RELX)

RELX Group is a global provider of information and analytics for professional and business customers across industries.
Our goal is to help customers make better decisions, get better results and be more productive. We do this by leveraging a deep understanding of our customers to create innovative solutions which combine content and data with analytics and technology in global platforms.
The Group has customers in more than 180 countries and has offices in about 40 countries. The Group employs approximately 30,000 staff.
We operate in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions.

? Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity, and improve outcomes.   Advisors’ Opinion:

  • [By Joseph Griffin]

    First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Cherry Hill Mortgage Investment Corporation, incorporated on October 31, 2012, is a residential real estate finance company. The Company is focused on acquiring, investing in and managing residential mortgage assets in the United States. Its principal objective is to generate attractive current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The Company focuses on attaining this objective, subject to market conditions and availability and terms of financing, by selectively constructing and managing a targeted portfolio of Servicing Related Assets, residential mortgage-backed securities (RMBS), prime mortgage loans and other cashflowing residential mortgage assets. The Company operates its business through segments, including investments in RMBS; investments in Servicing Related Assets, and All Other. The Company’s targeted asset classes include servicing related assets consisting of mortgage servicing rights (MSRs) and Excess MSRs; RMBS, including Agency RMBS, residential mortgage pass-through certificates, collateralized mortgage obligations (CMOs) (interest-only security (IO) and inverse IOs) and to-be-announced (TBA), and prime mortgage loans. The Company is externally managed by Cherry Hill Mortgage Management, LLC.

The Company also may generate MSRs through the purchase of prime mortgage loans. Its RMBS strategy focuses primarily on the acquisition and ownership of Agency RMBS that are whole-pool, residential mortgage pass-through certificates. However, from time to time, the Company invests in CMOs, including IOs and inverse IOs. Its RMBS strategy includes selective investments in non-Agency RMBS, including government-sponsored enterprise (GSE) risk-sharing securities.

Advisors’ Opinion:

  • [By Max Byerly]

    Cherry Hill Mortgage Investment (NYSE:CHMI) and Great Portland Estates (OTCMKTS:GPEAF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

  • [By Ethan Ryder]

    Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.

Top 10 Medical Stocks To Own Right Now: Briggs & Stratton Corporation(BGG)

Briggs & Stratton Corporation designs, manufactures, markets, sells, and services air cooled gasoline engines for outdoor power equipment. It operates in two segments, Engines and Products. The Engines segment offers four-cycle aluminum alloy gasoline engines that are used primarily by the lawn and garden equipment industry. Its products are used in various lawn and garden equipment applications, including walk-behind lawn mowers, riding lawn mowers, garden tillers, and snow throwers, as well as products for industrial, construction, agricultural, and other consumer applications that include portable and standby generators, pumps, and pressure washers. This segment also manufactures and sells replacement engines and service parts to sales and service distributors. The Products segment offers portable and standby generators, pressure washers, snow throwers, lawn and garden powered equipment, turf care, and job site products. This segment sells its products through various channels of retail distribution, including consumer home centers, warehouse clubs, mass merchants, and independent dealers under its brands, including Briggs & Stratton, Simplicity, Snapper, Snapper Pro, Ferris, PowerBoss, Allmand, Billy Goat, Murray, Branco, and Victa, as well as other brands, such as Craftsman, GE, and Troy-Bilt. The company serves original equipment manufacturers worldwide. Briggs & Stratton Corporation was founded in 1908 and is headquartered in Wauwatosa, Wisconsin.

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Briggs & Stratton (BGG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Generac Holdings Inc. (NYSE: GNRC) was up less than 1% at $59.20 late on Tuesday, but that is actually up by over 6% from last Friday’s close for the generator maker before the storm threat was so imminent. Briggs & Stratton Corp. (NYSE: BGG) is also in that field and its gain of just 0.3% to $20.45 late on Tuesday was actually up only about 1% from last Friday as the company is more diversified

  • [By Motley Fool Transcriber]

    Briggs & Stratton Corporation (NYSE: BGG)Q4 2018 Briggs & Stratton Corp Earnings CallAug. 16, 2018, 2 p.m. EDT

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: EP Energy Corporation(EPE)

EP Energy Corporation (EP Energy), incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company operates through a diverse base of producing assets and are focused on creating value through the development of its drilling inventory located in four areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont Field in the Uinta Basin (Northeastern Utah) and the Haynesville Shale (North Louisiana). In its operating areas, it has identified approximately 5,710 drilling locations (including over 860 drilling locations to which it has attributed proved undeveloped reserves).

The Company has proved reserves of approximately 546.0 million barrels of oil equivalent (MMBoe) and it has an average net daily production of over 109,680 barrel of oil equivalent per day (Boe/d). Approximately 240 MMBoe of its total proved reserves are proved developed producing assets, which generates an average production of over 109.7 million barrels of oil equivalent per day (MBoe/d) from approximately 1,600 wells. The Company has approximately 300 MMBbls of proved oil reserves, over 90 MMBbls of proved natural gas liquids (NGLs) reserves and approximately 940 billion cubic feet (Bcf) of proved natural gas reserves.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is an unconventional oil plays in the United States. The Eagle Ford formation in La Salle county has approximately 120 feet of net thickness (over 160 feet gross). The Company has approximately 94,150 net (over 88,890 gross) acres in the Eagle Ford, in which it has identified over 970 drilling locations. The Company has approximately 570 net producing wells (over 560 net operated wells) and running one rig in this program. EP Energy’s average net daily production is approximately 58,190 Boe/d.

!

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin. The Wolfcamp A, B and C zones combine for over 750 feet of net (approximately 1,000 feet of gross) thickness. The Company has approximately 178,110 net (over 178,280 gross) acres in the Wolfcamp, in which it has identified approximately 3,260 drilling locations in the Wolfcamp A, B and C zones. EP Energy has approximately 240 net operated producing wells. Its average net daily production is over 19,850 Boe/d.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. The Company’s operations are focused on developing the Altamont Field Complex (consisting of the Altamont, Bluebell and Cedar Rim fields). It owns approximately 180,940 net (over 323,210 gross) acres in Duchesne and Uinta Counties. The Altamont Field Complex has a gross pay interval thickness of over 4,300 feet. Its commingled production is from over 1,500 feet of net stimulated rock. The Company’s activity is focused on the development of its vertical inventory on approximately 80-acre and 160-acre spacing. The Company has identified approximately 1,280 drilling locations. EP Energy has approximately 390 net producing wells (over 380 net operated wells). The Company’s average net daily production is approximately 17,140 Boe/d.

Haynesville Shale

The Company holds natural gas assets in the Haynesville Shale, located in East Texas and Northern Louisiana. The Company’s operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. It has approximately 34,170 net (over 52,930 gross) acres in this area. EP Energy has identified over 190 drilling locations. The Company’s average net daily production is approximately 90 million cubic feet per day (MMcf/d).

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    EP Energy Corp  (NYSE:EPE)Q4 2018 Earnings Conference CallMarch 15, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enterprise GP (EPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enterprise GP Holdings L.P. (NYSE:EPE) shares were up 5.5% during trading on Wednesday . The stock traded as high as $2.55 and last traded at $2.51. Approximately 939,243 shares traded hands during mid-day trading, a decline of 13% from the average daily volume of 1,077,065 shares. The stock had previously closed at $2.38.

Top 10 Medical Stocks To Own Right Now: MuniVest Fund, Inc.(MVF)

BlackRock MuniVest Fund, Inc. (the Fund), formerly known as MuniVest Fund, Inc., is a non-diversified, closed-end management investment company. The Fund seeks to provide a high a level of current income exempt from federal income taxes by investing primarily in a portfolio of long-term, investment-grade municipal obligations, the interest on which is exempt from federal income taxes.

BlackRock MuniVest Fund, Inc. may invest in certain securities, whose income return is inversely related to changes in a floating interest rate (inverse floaters). The Fund may invest in swap agreements. The Fund may also purchase and write call and put options. BlackRock MuniVest Fund, Inc.’s investment advisor is BlackRock Advisors, LLC, a wholly owned subsidiary of BlackRock, Inc. The Fund’s sub-advisor is BlackRock Investment Management, LLC.

Advisors’ Opinion:

  • [By Max Byerly]

    BlackRock MuniVest Fund Inc. (NYSEAMERICAN:MVF) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be paid a dividend of 0.041 per share by the investment management company on Monday, October 1st. This represents a $0.49 annualized dividend and a dividend yield of 5.57%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 10 Medical Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company’s anti-infectives, including isavuconazole and ceftobiprole are in late-stage clinical development, while the novel antibiotic, BAL30072 and the oncology compound, BAL101553 are in clinical phase I. The Company’s subsidiaries include Basilea Pharmaceutica China Ltd., Basilea Pharmaceuticals A/S, Basilea Pharma SAS, Basilea Pharmaceutica Deutschland GmbH, Basilea Pharmaceutica International Ltd., BPh Investitionen Ltd., Basilea Medical Ltd. and Basilea Pharmaceuticals Ltd. Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Medical Stocks To Own Right Now: SunCoke Energy Partners, L.P.(SXCP)

SunCoke Energy Partners, L.P., (the “Partnership,” “we,” “our” and “us”), is a Delaware limited partnership formed in July 2012, which primarily produces coke used in the blast furnace production of steel. We also provide coal handling and/or mixing services at our Coal Logistics terminals. At December 31, 2015, we owned a 98.0 percent interest in Haverhill Coke Company LLC (“Haverhill”), Middletown Coke Company, LLC (“Middletown”) and Gateway Energy and Coke Company, LLC (“Granite City”). At December 31, 2015, SunCoke Energy, Inc. (“SunCoke”) owned the remaining 2.0 percent interest in each of Haverhill, Middletown, and Granite City, and, through its subsidiary, owned a 53.9 percent partnership interest in us and all of our incentive distribution rights and indirectly owns and controls our general partner, which holds a 2.0 percent general partner interest in us. Coke is a principal raw material in the blast furnace steelmaking process.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Bramshill Investments LLC cut its stake in SunCoke Energy Partners LP (NYSE:SXCP) by 4.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,454 shares of the energy company’s stock after selling 4,786 shares during the period. Bramshill Investments LLC’s holdings in SunCoke Energy Partners were worth $1,702,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE:SXCP) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Teligent (NASDAQ:TLGT) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get SunCoke Energy Partners alerts:

    SunCoke Energy Partners LP Declares Quarterly Dividend of $0.40 (SXCP) (americanbankingnews.com) SunCoke Energy Partners (SXCP) Scheduled to Post Earnings on Wednesday (americanbankingnews.com) SunCoke Energy Partners LP (SXCP) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Head to Head Survey: SunCoke Energy Partners (SXCP) vs. APERAM/SH N Y REGISTRY SH (APEMY) (americanbankingnews.com)

    Shares of SunCoke Energy Partners traded down $0.05, hitting $15.85, during trading on Friday, MarketBeat reports. 105,181 shares of the company were exchanged, compared to its average volume of 66,406. The firm has a market capitalization of $735.01 million, a price-to-earnings ratio of 9.61 and a beta of 1.44. SunCoke Energy Partners has a fifty-two week low of $14.70 and a fifty-two week high of $21.95. The company has a quick ratio of 0.83, a current ratio of 1.54 and a debt-to-equity ratio of 1.34.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 10 Medical Stocks To Own Right Now: TG Therapeutics, Inc.(TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Todd Campbell]

    Fueled by trial data, TG Therapeutics (NASDAQ:TGTX) shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

    So what

    On Jan. 30, data from phase 1 trials evaluating TG Therapeutics’ ublituximab and umbralisib alongside J&J and AbbVie’s Imbruvica was published in Lancet, a respected industry journal. 

  • [By Logan Wallace]

    Shares of TG Therapeutics Inc (NASDAQ:TGTX) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $12.30.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

Top 10 Stocks To Own Right Now

Los Angeles, CA, based Investment company Rnc Capital Management Llc buys Sempra Energy, Citigroup Inc, Walgreens Boots Alliance Inc, Carnival Corp, Philip Morris International Inc, Cisco Systems Inc, Bank of Hawaii Corp, ServiceNow Inc, Usana Health Sciences Inc, Rockwell Automation Inc, sells Pfizer Inc, SunTrust Banks Inc, Johnson Controls International PLC, BlackRock Inc, United Technologies Corp during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Rnc Capital Management Llc. As of 2018-06-30, Rnc Capital Management Llc owns 134 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

New Purchases: BOH, NOW, CAE, ROK, USNA, APTV, Added Positions: SRE, C, WBA, CCL, PM, CSCO, SLB, VZ, OMC, RDS.A, Reduced Positions: PFE, STI, BLK, UTX, XOM, BTI, LOW, GOOGL, TSN, NFX, Sold Out: JCI, AJG, EIX, MDLZ, KO, ITW, IFF, HE, FFIV, FDX,

For the details of RNC CAPITAL MANAGEMENT LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=RNC+CAPITAL+MANAGEMENT+LLC

Top 10 Stocks To Own Right Now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Westell Technologies, Inc. (NASDAQ: WSTL) was down, falling around 19 percent to $2.815 after reporting a fourth-quarter earnings miss.

    Commodities

  • [By Lisa Levin]

    Westell Technologies, Inc. (NASDAQ: WSTL) was down, falling around 19 percent to $2.81 after reporting a fourth-quarter earnings miss.

    Commodities

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Recro Pharma, Inc. (NASDAQ: REPH) fell 50.3 percent to $6.17 in pre-market trading after the company received a Complete Response Letter from the FDA. The FDA declined to approve the company’s New Drug Application for IV meloxicam.
    Westell Technologies, Inc. (NASDAQ: WSTL) shares fell 16.5 percent to $2.89 in pre-market trading after the company announced Q4 results.
    Melinta Therapeutics, Inc. (NASDAQ: MLNT) fell 16.5 percent to $5.20 in pre-market trading after reporting pricing of public offering of common stock.
    Westmoreland Resource Partners, LP (NYSE: WMLP) fell 11 percent to $3.49 in pre-market trading after surging 194.03 percent on Wednesday.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) shares fell 11 percent to $13.45 in pre-market trading. Petrobras announced plans to lower the cost of diesel by 10 percent.
    Sanderson Farms, Inc. (NASDAQ: SAFM) shares fell 9.4 percent to $97 in pre-market trading after the company reported weaker-than-expected results for its second quarter.
    Zealand Pharma A/S (NASDAQ: ZEAL) fell 6.9 percent to $15.55 in pre-market trading after rising 2.71 percent on Wednesday.
    L Brands, Inc. (NYSE: LB) shares fell 6.7 percent to $31.76 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company issued weak second quarter and FY18 earnings guidance.
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) shares fell 5.9 percent to $4.78 in pre-market trading.
    Qiwi plc (NASDAQ: QIWI) fell 5.9 percent to $17.52 in pre-market trading.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) fell 5 percent to $13.25 in pre-market trading after reporting a proposed offering of common stock.
    Best Buy Co Inc (NYSE: BBY) shares fell 4.3 percent to $72.66 in pre-market trading. Best Buy reported better-than-expected earnings for its first quarter.
    NetApp Inc. (NASDAQ: NTAP) fell 4.1 percent to $64.

Top 10 Stocks To Own Right Now: Equity Residential(EQR)

Advisors’ Opinion:

  • [By Logan Wallace]

    DiamondRock Hospitality (NYSE:DRH) and Equity Residential (NYSE:EQR) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Equity Residential (NYSE:EQR) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,723 shares of the real estate investment trust’s stock after buying an additional 827 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.05% of Equity Residential worth $12,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Equity Residential (EQR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Equity Residential (NYSE:EQR) Vice Chairman Gerald A. Spector sold 13,024 shares of the business’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $67.50, for a total transaction of $879,120.00. Following the completion of the sale, the insider now owns 294,287 shares in the company, valued at $19,864,372.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

  • [By Ethan Ryder]

    Oppenheimer Asset Management Inc. decreased its position in shares of Equity Residential (NYSE:EQR) by 23.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 25,650 shares of the real estate investment trust’s stock after selling 7,654 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Equity Residential were worth $1,580,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Ethan Ryder]

    Equity Residential (NYSE:EQR) had its target price lowered by Morgan Stanley from $66.50 to $63.00 in a report released on Thursday. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s target price points to a potential downside of 0.76% from the stock’s previous close.

Top 10 Stocks To Own Right Now: Blue Capital Reinsurance Holdings Ltd.(BCRH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RLI (NYSE: BCRH) and Blue Capital Reinsurance (NYSE:BCRH) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Max Byerly]

    News articles about Blue Capital Reinsurance (NYSE:BCRH) have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blue Capital Reinsurance earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news headlines about the insurance provider an impact score of 47.9769004082468 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Akari Therapeutics alerts:

    Akari Therapeutics, Plc (AKTX) Analysts See $-1.00 EPS; HC INTERNATIONAL ORDINARY SHARES CA (HCINF … (mtastar.com) Trader’s Buzzers- Boxlight Corporation (NASDAQ:BOXL), Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH), Akari … (journalfinance.net) Akari Therapeutics (AKTX) Lifted to “Hold” at ValuEngine (americanbankingnews.com) Guillain-Barre Syndrome Market to reach value of US$ 708.6 Mn by 2025, Says TMRGlobal Guillain–Barre Syndrome … (markets.businessinsider.com) Analysts See $-1.00 EPS for Akari Therapeutics, Plc (AKTX); Verastem (VSTM) SI Decreased By 7.78% (mtastar.com)

    Several brokerages have commented on AKTX. ValuEngine upgraded Akari Therapeutics from a “sell” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity cut their target price on Akari Therapeutics from $15.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, March 29th. B. Riley began coverage on Akari Therapeutics in a research note on Thursday, February 8th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, Zacks Investment Research downgraded Akari Therapeutics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $4.63.

  • [By Shane Hupp]

    Blue Capital Reinsurance (NYSE:BCRH) reached a new 52-week high and low during trading on Thursday . The company traded as low as $10.90 and last traded at $11.05, with a volume of 17133 shares trading hands. The stock had previously closed at $11.20.

Top 10 Stocks To Own Right Now: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Kubera Coin (CURRENCY:KBR) traded up 1.2% against the dollar during the one day period ending at 11:00 AM ET on August 26th. In the last week, Kubera Coin has traded up 66.9% against the dollar. One Kubera Coin token can now be bought for $0.0027 or 0.00000041 BTC on popular cryptocurrency exchanges including HitBTC and Cryptopia. Kubera Coin has a total market capitalization of $311,598.00 and approximately $6,830.00 worth of Kubera Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    KBR, Inc. (NYSE:KBR) announced a quarterly dividend on Friday, August 10th, Wall Street Journal reports. Investors of record on Monday, September 17th will be given a dividend of 0.08 per share by the construction company on Monday, October 15th. This represents a $0.32 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Friday, September 14th.

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies… within the Government Services and Hydrocarbon sectors.”

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own Right Now: Big 5 Sporting Goods Corporation(BGFV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Big 5 Sporting Goods alerts:

    Why Big 5 Sporting Goods Corporation (BGFV) Could Shock the Market Soon (zacks.com) Big 5 Sporting Goods (BGFV) Cut to Sell at ValuEngine (americanbankingnews.com) It’s Time To Sell Big 5 Sporting Goods (seekingalpha.com) Big 5 Sporting Goods Corp Stock [FallsFell] as Big Money Exit, Sentiment at 0.82 (thecasualsmart.com) A Look at Some Alternative Metrics For Big 5 Sporting Goods Corporation (NasdaqGS:BGFV) (derbynewsjournal.com)

    Several analysts have weighed in on BGFV shares. Zacks Investment Research raised shares of Big 5 Sporting Goods from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 13th. ValuEngine raised shares of Big 5 Sporting Goods from a “sell” rating to a “hold” rating in a research report on Wednesday, March 7th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $9.08.

  • [By ]

    Yet, while imperfect, this little figure can help pinpoint underpriced stocks that have room to climb, especially when book value is rising. That just might be the case with sporting goods retailer Big Five (Nasdaq: BGFV). The company operates 435 stores in 11 states, selling everything from camping gear to snow skis.

  • [By Max Byerly]

    Press coverage about Big 5 Sporting Goods (NASDAQ:BGFV) has trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Big 5 Sporting Goods earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 48.2140595662163 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Citigroup Inc. lifted its holdings in shares of Big 5 Sporting Goods Co. (NASDAQ:BGFV) by 5,069.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,559 shares of the company’s stock after buying an additional 15,258 shares during the period. Citigroup Inc. owned about 0.07% of Big 5 Sporting Goods worth $112,000 at the end of the most recent quarter.

Top 10 Stocks To Own Right Now: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Max Byerly]

    Williams-Sonoma (NYSE:WSM) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $4.26-4.36 for the period, compared to the Thomson Reuters consensus estimate of $4.24. The company issued revenue guidance of $5.57-5.67 billion, compared to the consensus revenue estimate of $5.62 billion.Williams-Sonoma also updated its Q3 guidance to $0.90-0.95 EPS.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Lisa Levin]

    Breaking news

    Best Buy Co., Inc. (NYSE: BBY) reported better-than-expected earnings for its first quarter.
    Sanderson Farms, Inc. (NASDAQ: SAFM) reported weaker-than-expected results for its second quarter.
    Medtronic plc (NYSE: MDT) reported upbeat earnings for its fourth quarter on Thursday.
    Williams-Sonoma, Inc. (NYSE: WSM) reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe

Top 10 Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Stocks To Own Right Now: Finjan Holdings, Inc.(FNJN)

Advisors’ Opinion:

  • [By Max Byerly]

    Marathon Patent Group (NASDAQ: MARA) and Finjan (NASDAQ:FNJN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

  • [By Max Byerly]

    Finjan Holdings Inc (NASDAQ:FNJN) shares saw an uptick in trading volume on Tuesday . 32,387 shares changed hands during trading, a decline of 93% from the previous session’s volume of 494,407 shares.The stock last traded at $4.98 and had previously closed at $5.08.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    ValuEngine upgraded shares of Finjan (NASDAQ:FNJN) from a hold rating to a buy rating in a research report sent to investors on Monday.

    Separately, TheStreet upgraded Finjan from a c+ rating to a b- rating in a research report on Tuesday, August 14th.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Finjan alerts:

    You Need To Taste These: Finjan Holdings, Inc. (NASDAQ:FNJN), The Dixie Group, Inc. (NASDAQ:DXYN), Sky Solar … (thestreetpoint.com) With a 125/250 Day Adjusted Slope of 63.35003, Is Finjan Holdings, Inc. (NasdaqCM:FNJN) a Favorable Pick? (cantoncaller.com) Which Option is Best? Finjan Holdings, Inc. (FNJN) Buy or Sell (topdesertsafari.com) Finjan Holdings Inc (FNJN) Given Average Recommendation of “Strong Buy” by Analysts (americanbankingnews.com)

    Several research analysts recently issued reports on the stock. TheStreet raised shares of Finjan from a “c+” rating to a “b-” rating in a report on Tuesday, August 14th. Dawson James reissued a “buy” rating on shares of Finjan in a report on Tuesday, May 22nd. Finally, ValuEngine cut shares of Finjan from a “buy” rating to a “hold” rating in a report on Thursday, August 2nd.

Top 10 Stocks To Own Right Now: Israel Chemicals Shs(ICL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Itasca Capital Ltd (CVE:ICL) Director Richard Michael Powell bought 25,000 shares of the company’s stock in a transaction on Monday, August 13th. The shares were bought at an average cost of C$0.57 per share, for a total transaction of C$14,250.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Israel Chemicals (ICL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Israel Chemicals (NYSE: ICL) and Evogene (NASDAQ:EVGN) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Israel Chemicals (NYSE:ICL) – Equities researchers at Jefferies Group issued their Q2 2018 earnings per share estimates for shares of Israel Chemicals in a research note issued on Monday, May 14th. Jefferies Group analyst L. Alexander forecasts that the basic materials company will post earnings of $0.09 per share for the quarter. Jefferies Group also issued estimates for Israel Chemicals’ Q3 2018 earnings at $0.11 EPS and Q4 2018 earnings at $0.10 EPS.

  • [By Stephan Byrd]

    Israel Chemicals (NYSE:ICL) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Kingstone Companies (NASDAQ:KINS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Top 10 Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alexander Bird]

    Here are the top performers from last week…

    Penny Stock Current Share Price Last Week’s Gain
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
    Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
    Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
    Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
    Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
    Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
    Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
    Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
    ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
    SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%

    While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.

  • [By Shane Hupp]

    News stories about Ascent Capital Group Inc Series A (NASDAQ:ASCMA) have trended somewhat negative on Wednesday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ascent Capital Group Inc Series A earned a news sentiment score of -0.02 on Accern’s scale. Accern also assigned news coverage about the industrial products company an impact score of 46.5362897974896 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top High Tech Stocks To Watch Right Now

Summary

Viper Energy (NASDAQ:VNOM) is an MLP that owns mineral and royalty interests and is 75% owned by Diamondback Energy (NASDAQ:FANG). It is one of the cleanest and easiest to understand MLPs in the energy space. The business model is simple: the company collects royalty checks on its mineral/royalty acreage (averaging 9.1% of revenue of the oil and gas produced) and has few overhead costs. There are no Incentive Distribution Rights (IDRs), the balance sheet is completely debt-free, and it is majority owned by one of the fastest-growing Permian producers in the US.

Given that Viper owns mineral rights, there is no capex or opex either. While these admittedly are not businesses that trade at cheap multiples, these are fantastic businesses that can grow without any need for capital expenditures, and benefit from higher production on their acreage as well as higher oil and gas prices.

There are 2 other publicly traded royalty trusts in the market, Black Stone Minerals (NYSE:BSM) and Prairie Sky (PSK.CN) in Canada. BSM trades at 21x 2017 Free Cash Flow (FCF) and PSK at 24x 2017 FCF. While Viper hasn’t provided production guidance for 2017 yet, I am expecting 40% growth this year. Just using current commodity prices ($54 oil and $2.50 gas), Viper should throw off $1.18 in FCF/unit, meaning it trades at only 15x 2017 FCF. That is a remarkable 35% discount to the peers.

Top High Tech Stocks To Watch Right Now: Tel-Instrument Electronics Corp.(TIK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tel-Instrument Electronics Corp. (NYSE: TIK) got a boost, shooting up 54 percent to $3.55 after the company reported $1 million of new orders.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

Top High Tech Stocks To Watch Right Now: Opko Health Inc(OPK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Opko Health Inc. (NASDAQ: OPK) dropped nearly 15% on Thursday to record a new 52-week low of $7.13 against a high of $12.15. The stock closed at $8.37 on Wednesday. Volume was more than 3 times the daily average of around 4.9 million shares. The company reported a worse-than-expected loss after markets closed last night.

  • [By Cory Renauer]

    Shares of multinational pharmaceutical and diagnostics companyOpko Health, Inc. (NASDAQ:OPK)are feeling the heat after reporting fourth-quarter and full-year 2016 earnings. Despite a major thumping late last year, the stock gave up another 10.5% as of 3:31 p.m. on Thursday.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top High Tech Stocks To Watch Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Leuven, Belgium-based Tigenix (OTC:TGXSF) filed to go public in the U.S. in late 2015, only to become entangled with Bavarian Nordic (OTC:BVNKF) and Basilea Pharmaceutica (OTC:BPMUF) as the European drugmakers pulled back from NASDAQ. Tigenix subsequently increased its bank account following a 23.75 million placement in Belgium, and added an additional 25 million via a relationship with Takeda, before coming back to Wall Street in October 2016 with a revamped slate of underwriters.

Top High Tech Stocks To Watch Right Now: IPG Photonics Corporation(IPGP)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday began on a down note for the stock market, as the Dow Jones Industrials fell back down below the 20,000 level. Major market benchmarks finished with losses of 0.6% to 0.8%, and some market commentators attributed the declines to nervousness about the Trump administration’s actions to clamp down on immigration. Others noted that the latest reading of U.S. economic growth showed a 1.9% rise in gross domestic product for the fourth quarter, finishing the year with an overall GDP increase of just 1.6%, down a full percentage point from 2015’s growth. Despite the overall sullen mood in the market, some stocks gained ground, and GoPro (NASDAQ:GPRO), Movado Group (NYSE:MOV), and IPG Photonics (NASDAQ:IPGP) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Ethan Ryder]

    Princeton Capital Management LLC grew its position in IPG Photonics (NASDAQ:IPGP) by 3.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,998 shares of the semiconductor company’s stock after acquiring an additional 421 shares during the quarter. IPG Photonics accounts for about 1.2% of Princeton Capital Management LLC’s holdings, making the stock its 27th largest position. Princeton Capital Management LLC’s holdings in IPG Photonics were worth $2,800,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Advantus Capital Management Inc reduced its position in shares of IPG Photonics (NASDAQ:IPGP) by 16.5% during the first quarter, HoldingsChannel reports. The firm owned 3,859 shares of the semiconductor company’s stock after selling 763 shares during the period. Advantus Capital Management Inc’s holdings in IPG Photonics were worth $901,000 as of its most recent SEC filing.